Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06260878
PHASE4

Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

Sponsor: University of Calgary

View on ClinicalTrials.gov

Summary

This study will explore the efficacies of several practical short-term (peri-procedural) intravenous fluid regimens in the prevention of post- endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). PEP is the most common serious ERCP-related adverse event (AE), occurring in 5-15% of patients, and associated with significant morbidity, mortality, and healthcare utilization. Given the current lack of data on effectiveness of short-term fluid regimens in PEP prevention to inform practice, the results of the proposed study have the strong potential to impact ERCP practices worldwide, whether positive or negative.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

505

Start Date

2024-11-22

Completion Date

2028-06-30

Last Updated

2024-12-20

Healthy Volunteers

Yes

Interventions

OTHER

Intravenous Ringer's lactate

Intravenous Ringer's lactate

Locations (1)

Peter Lougheed Centre

Calgary, Alberta, Canada